ADIPOQ and chronic kidney disease: Therefore, by investigating the association between the two parameters in hemodialysis patients who do not have residual renal function, it may be possible to determine whether the conversion from a negative to a positive association between serum adiponectin and AAC in pre-dialysis CKD patients is a true association and not an event secondary to the impaired urinary excretion of adiponectin.